Get To Know the Key People Behind Beta Cell Replacement Therapy in Boston
Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the…
Join Us “Inside the Lab at Boston”
The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a…
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use…
Breakthrough T1D Names Aaron Kowalski New President and CEO
Chief Mission Officer to assume leadership baton from Derek Rapp After a thorough national search, the Breakthrough T1D International Board…
Breakthrough T1D Leaders Jeff Plumer and Sanjoy Dutta Join Editorial Advisory Boards of Two Top Diabetes Publications
Two of the world’s most respected and trusted health publications have tapped Breakthrough T1D to serve as an expert voice…
Testimony of Dr. Aaron Kowalski, Chief Mission Officer, Breakthrough T1D House Energy & Commerce Committee Oversight And Investigations Subcommittee
‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone,…
Insulin pumps, CGMs and more: is T1D Tech right for you?
Hear from six people living with T1D about their #T1DTech, the fears they had before using their various devices, and…
European Commission Has Approved Forxiga for Adults with Type 1 Diabetes
It’s official: The European Commission has approved Forxiga® (dapagliflozin and marketed in the United States as Farxiga®) for adults with…
